NASDAQ:TRNS - Transcat Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$16.90 0.00 (0.00 %)
(As of 05/22/2018 04:00 PM ET)
Previous Close$16.90
Today's Range$16.90 - $17.10
52-Week Range$11.80 - $17.45
Volume4,700 shs
Average Volume11,947 shs
Market Capitalization$121.24 million
P/E Ratio26.41
Dividend YieldN/A

About Transcat (NASDAQ:TRNS)

Transcat logoTranscat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to integrate and manage the workflow of its calibration service centers and customers' assets; CalTrak Online, which provides its customers with Web-based asset management capability, as well as an off-site archive of calibration and other service records; and Compliance, Control and Cost, a cloud-based customer portal and asset management tool. The Distribution segment distributes approximately 100,000 test, measurement, and control instruments for customers' test and measurement instrumentation needs. This segment markets and sells its products through Website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including industrial manufacturing, oil and gas and alternative energy, aerospace and defense, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York.

Receive TRNS News and Ratings via Email

Sign-up to receive the latest news and ratings for TRNS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Instruments to measure electricity
SectorComputer and Technology


Debt-to-Equity Ratio0.50
Current Ratio1.98
Quick Ratio1.38


Trailing P/E Ratio26.41
Forward P/E Ratio24.14
P/E Growth2.34

Sales & Book Value

Annual Sales$143.90 million
Price / Sales0.84
Cash Flow$1.5198 per share
Price / Cash11.12
Book Value$6.18 per share
Price / Book2.73


EPS (Most Recent Fiscal Year)$0.64
Net Income$4.52 million
Net Margins3.24%
Return on Equity10.03%
Return on Assets4.94%


Outstanding Shares7,150,000

Transcat (NASDAQ:TRNS) Frequently Asked Questions

What is Transcat's stock symbol?

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) released its quarterly earnings results on Tuesday, October, 25th. The scientific and technical instruments company reported $0.12 EPS for the quarter. The scientific and technical instruments company had revenue of $34.49 million for the quarter, compared to analyst estimates of $29.48 million. Transcat had a return on equity of 10.03% and a net margin of 3.24%. View Transcat's Earnings History.

When is Transcat's next earnings date?

Transcat is scheduled to release their next quarterly earnings announcement on Wednesday, May, 23rd 2018. View Earnings Estimates for Transcat.

What price target have analysts set for TRNS?

3 Wall Street analysts have issued 1 year price objectives for Transcat's stock. Their predictions range from $20.00 to $20.00. On average, they expect Transcat's stock price to reach $20.00 in the next twelve months. View Analyst Ratings for Transcat.

Who are some of Transcat's key competitors?

Who are Transcat's key executives?

Transcat's management team includes the folowing people:
  • Mr. Lee D. Rudow, Pres, CEO & Director (Age 54)
  • Mr. Michael J Tschiderer, VP of Fin., CFO, Treasurer & Corp. Sec. (Age 58)
  • Mr. Robert A. Flack, VP of Service Sales & Operations (Age 48)
  • Mr. Scott D. Deverell, Corp. Controller & Principal Accounting Officer (Age 52)
  • Mr. Michael W. West, VP of Marketing & Inside Sales (Age 47)

Has Transcat been receiving favorable news coverage?

Media coverage about TRNS stock has trended somewhat positive recently, Accern Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Transcat earned a coverage optimism score of 0.13 on Accern's scale. They also assigned news headlines about the scientific and technical instruments company an impact score of 46.69 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Transcat's major shareholders?

Transcat's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (4.42%), WCM Investment Management CA (4.22%), Dalton Greiner Hartman Maher & Co. (3.10%), Neuberger Berman Group LLC (1.87%), Quantum Capital Management (1.17%) and UBS Group AG (0.93%). Company insiders that own Transcat stock include Angela J Panzarella, Carl E Sassano, Charles P Hadeed, John T Smith, Michael Tschiderer, Paul D Moore and Robert A Flack. View Institutional Ownership Trends for Transcat.

Which major investors are selling Transcat stock?

TRNS stock was sold by a variety of institutional investors in the last quarter, including WCM Investment Management CA, Dalton Greiner Hartman Maher & Co., QCI Asset Management Inc. NY and Neuberger Berman Group LLC. Company insiders that have sold Transcat company stock in the last year include Carl E Sassano, John T Smith and Paul D Moore. View Insider Buying and Selling for Transcat.

Which major investors are buying Transcat stock?

TRNS stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG, Segall Bryant & Hamill LLC, Quantum Capital Management, Hancock Holding Co., Dimensional Fund Advisors LP and ZPR Investment Management. Company insiders that have bought Transcat stock in the last two years include Angela J Panzarella, Michael Tschiderer and Robert A Flack. View Insider Buying and Selling for Transcat.

How do I buy shares of Transcat?

Shares of TRNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Transcat's stock price today?

One share of TRNS stock can currently be purchased for approximately $16.90.

How big of a company is Transcat?

Transcat has a market capitalization of $121.24 million and generates $143.90 million in revenue each year. The scientific and technical instruments company earns $4.52 million in net income (profit) each year or $0.64 on an earnings per share basis. Transcat employs 585 workers across the globe.

How can I contact Transcat?

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The scientific and technical instruments company can be reached via phone at 585-352-7777 or via email at [email protected]

MarketBeat Community Rating for Transcat (TRNS)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  59 (Vote Underperform)
Total Votes:  142
MarketBeat's community ratings are surveys of what our community members think about Transcat and other stocks. Vote "Outperform" if you believe TRNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRNS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Transcat (NASDAQ:TRNS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Transcat in the last 12 months. Their average twelve-month price target is $20.00, suggesting that the stock has a possible upside of 18.34%. The high price target for TRNS is $20.00 and the low price target for TRNS is $20.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $20.00$20.00$20.00$17.65
Price Target Upside: 18.34% upside32.45% upside32.45% upside41.77% upside

Transcat (NASDAQ:TRNS) Consensus Price Target History

Price Target History for Transcat (NASDAQ:TRNS)

Transcat (NASDAQ:TRNS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2018Roth CapitalInitiated CoverageBuy ➝ Buy$20.00HighView Rating Details
2/5/2018Singular ResearchBoost Price TargetBuy ➝ Buy$15.30 ➝ $20.00LowView Rating Details
8/23/2017Dougherty & CoInitiated CoverageBuy ➝ Buy$20.00MediumView Rating Details
(Data available from 5/22/2016 forward)


Transcat (NASDAQ:TRNS) Earnings History and Estimates Chart

Earnings by Quarter for Transcat (NASDAQ:TRNS)

Transcat (NASDAQ:TRNS) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20181$0.11$0.11$0.11
Q3 20181$0.12$0.12$0.12
Q4 20181$0.18$0.18$0.18

Transcat (NASDAQ TRNS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/23/2018Q4$0.23$0.3410N/AView Earnings Details
1/29/2018Q3 2018$0.12$0.21$40.48 millionViewN/AView Earnings Details
10/24/2017Q2 2018$0.11$0.11$35.93 millionViewN/AView Earnings Details
7/25/2017Q1 2018$0.12$36.28 millionViewN/AView Earnings Details
5/16/2017Q4 2017$0.1990$38.45 millionViewN/AView Earnings Details
1/30/2017Q317$0.18$37.81 millionViewN/AView Earnings Details
10/25/2016Q217$0.12$29.48 million$34.49 millionViewN/AView Earnings Details
7/26/2016Q117$0.12$29.67 million$33.15 millionViewN/AView Earnings Details
5/17/2016Q416$0.22$32.40 million$32.90 millionViewN/AView Earnings Details
1/25/2016Q316$0.15$31.05 million$30.16 millionViewListenView Earnings Details
10/26/2015Q216$0.12$31.10 million$29.50 millionViewListenView Earnings Details
7/29/2015Q116$0.08$29.12 million$29.70 millionViewListenView Earnings Details
5/19/2015Q4 2015$0.27$32.34 millionViewN/AView Earnings Details
1/26/2015Q315$0.11$31.51 million$31.05 millionViewN/AView Earnings Details
10/27/2014Q2 15$0.12$31.11 millionViewN/AView Earnings Details
7/29/2014Q1 2015$0.06$29.12 millionViewN/AView Earnings Details
5/20/2014$0.20$0.24$30.40 millionViewN/AView Earnings Details
1/27/2014Q4$0.10$30.51 millionViewN/AView Earnings Details
10/28/2013Q2 2014$0.13$0.10$28.88 millionViewN/AView Earnings Details
7/30/2013Q1 2014$0.09$28.71 millionViewN/AView Earnings Details
5/21/2013Q4 2013$0.24$31.09 millionViewN/AView Earnings Details
1/28/2013Q3 2013$0.10ViewN/AView Earnings Details
10/29/2012Q2 2013$0.10ViewN/AView Earnings Details
7/31/2012Q1 2013$0.05ViewN/AView Earnings Details
5/21/2012Q4 2012$0.16ViewN/AView Earnings Details
1/23/2012Q3 2012$0.13ViewN/AView Earnings Details
10/31/2011Q2 2012$0.10ViewN/AView Earnings Details
7/26/2011Q1 2012$0.04ViewN/AView Earnings Details
5/19/2011Q4 2011$0.14ViewN/AView Earnings Details
1/24/2011Q3 2011$0.12ViewN/AView Earnings Details
10/25/2010Q2 2011$0.07ViewN/AView Earnings Details
7/26/2010Q1 2011$0.04ViewN/AView Earnings Details
5/20/2010Q4 2010$0.12ViewN/AView Earnings Details
1/25/2010Q3 2010$0.06ViewN/AView Earnings Details
10/26/2009Q2 2010$0.02ViewN/AView Earnings Details
7/27/2009Q1 2010($0.01)ViewN/AView Earnings Details
5/20/2009Q4 2009$0.07ViewN/AView Earnings Details
1/28/2009Q3 2009$0.05ViewN/AView Earnings Details
10/30/2008Q2 2009$0.06ViewN/AView Earnings Details
7/24/2008Q1 2009$0.03ViewN/AView Earnings Details
5/21/2008Q4 2008$0.10ViewN/AView Earnings Details
1/29/2008Q3 2008$0.06ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Transcat (NASDAQ:TRNS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Transcat (NASDAQ TRNS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.80%
Institutional Ownership Percentage: 54.53%
Insider Trading History for Transcat (NASDAQ:TRNS)
Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Transcat (NASDAQ TRNS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/23/2018Michael TschidererCFOBuy200$15.40$3,080.00View SEC Filing  
2/1/2018John T SmithDirectorSell2,000$15.70$31,400.0033,100View SEC Filing  
11/13/2017Michael TschidererCFOBuy500$12.34$6,170.00View SEC Filing  
11/2/2017Robert A. FlackVPBuy1,100$12.30$13,530.00View SEC Filing  
8/4/2017Paul D MooreDirectorSell4,000$13.00$52,000.0057,698View SEC Filing  
7/31/2017Carl E SassanoDirectorSell7,500$13.02$97,650.0079,075View SEC Filing  
6/14/2017Robert A FlackVPBuy243$11.90$2,891.707,178View SEC Filing  
6/13/2017Michael TschidererVPBuy100$11.90$1,190.00View SEC Filing  
6/12/2017Robert A. FlackVPBuy738$11.90$8,782.20View SEC Filing  
6/1/2017Angela J PanzarellaDirectorBuy1,000$12.06$12,060.0012,000View SEC Filing  
1/19/2017Angela J PanzarellaDirectorBuy1,000$10.68$10,680.0011,000View SEC Filing  
11/7/2016Michael TschidererVPBuy580$10.20$5,916.00View SEC Filing  
11/1/2016Robert A. FlackVPBuy2,000$10.20$20,400.00View SEC Filing  
8/26/2016Charles P HadeedChairmanSell937$10.80$10,119.6082,772View SEC Filing  
8/25/2016Charles P HadeedChairmanSell5,100$10.87$55,437.0087,809View SEC Filing  
8/23/2016Charles P HadeedChairmanSell1,796$10.88$19,540.4889,912View SEC Filing  
8/19/2016Charles P HadeedChairmanSell2,000$10.55$21,100.0091,605View SEC Filing  
8/17/2016Charles P HadeedChairmanSell2,267$10.50$23,803.5094,305View SEC Filing  
6/15/2016Charles P HadeedChairmanSell840$10.50$8,820.0094,872View SEC Filing  
6/14/2016Charles P HadeedChairmanSell7,020$10.50$73,710.0098,800View SEC Filing  
6/13/2016Charles P HadeedChairmanSell3,932$10.50$41,286.0098,800View SEC Filing  
6/7/2016Charles P HadeedChairmanSell40$10.50$420.00102,732View SEC Filing  
5/25/2016Carl E SassanoDirectorSell8,800$9.70$85,360.0086,575View SEC Filing  
5/20/2016Carl E SassanoDirectorSell1,200$9.75$11,700.0095,375View SEC Filing  
5/20/2016Michael TschidererCFOBuy1,500$9.62$14,430.002,825View SEC Filing  
9/2/2015Francis R BradleyDirectorSell6,000$9.24$55,440.0022,048View SEC Filing  
5/27/2015Charles P HadeedChairmanSell20,000$10.01$200,200.00View SEC Filing  
3/16/2015Gary J HaseleyDirectorBuy7,484$9.34$69,900.56View SEC Filing  
1/30/2015Carl E SassanoDirectorSell17,516$9.39$164,475.24View SEC Filing  
11/19/2014Charles P HadeedChairmanSell3,877$10.01$38,808.77View SEC Filing  
6/4/2014Charles P HadeedChairmanSell20,000$9.53$190,600.00View SEC Filing  
5/28/2014Lee D RudowCEOBuy2,000$9.00$18,000.00View SEC Filing  
5/27/2014Alan H ResnickDirectorBuy5,000$9.22$46,100.00View SEC Filing  
2/11/2014Carl E SassanoDirectorSell5,000$8.78$43,900.00View SEC Filing  
2/7/2014Carl E SassanoDirectorSell5,900$8.58$50,622.00View SEC Filing  
2/5/2014Carl E SassanoDirectorSell3,100$8.52$26,412.00View SEC Filing  
2/3/2014Carl E SassanoDirectorSell5,900$160.44$946,596.00View SEC Filing  
11/13/2013Richard J HarrisonDirectorBuy2,000$7.80$15,600.00View SEC Filing  
8/27/2013Nancy D HesslerDirectorSell1,789$8.01$14,329.89View SEC Filing  
11/15/2012Alan H ResnickDirectorBuy2,500$5.80$14,500.00View SEC Filing  
11/13/2012Alan H ResnickDirectorBuy2,500$5.80$14,500.00View SEC Filing  
11/8/2012John T SmithDirectorBuy9,600$5.97$57,312.00View SEC Filing  
11/7/2012Paul D MooreDirectorBuy3,000$5.86$17,580.00View SEC Filing  
11/5/2012Lee D RudowCOOBuy3,700$5.56$20,572.00View SEC Filing  
11/5/2012Paul D MooreDirectorBuy3,000$5.60$16,800.00View SEC Filing  
11/2/2012John J ZimmerCFOBuy3,000$5.35$16,050.00View SEC Filing  
11/2/2012John T SmithDirectorBuy3,700$5.23$19,351.00View SEC Filing  
11/2/2012Lee D RudowCOOBuy5,600$5.21$29,176.00View SEC Filing  
8/16/2012Lee D RudowCOOBuy8,000$6.20$49,600.00View SEC Filing  
8/9/2012Richard J HarrisonDirectorBuy4,600$6.68$30,728.00View SEC Filing  
8/8/2012Alan H ResnickDirectorBuy5,000$6.49$32,450.00View SEC Filing  
(Data available from 1/1/2013 forward)


Transcat (NASDAQ TRNS) News Headlines

Zacks: Transcat, Inc. (TRNS) Given Consensus Rating of "Strong Buy" by AnalystsZacks: Transcat, Inc. (TRNS) Given Consensus Rating of "Strong Buy" by Analysts - May 20 at 3:33 PM
Transcat (TRNS) Scheduled to Post Earnings on WednesdayTranscat (TRNS) Scheduled to Post Earnings on Wednesday - May 16 at 2:12 AM
Analyzing Cohu (COHU) and Transcat (TRNS)Analyzing Cohu (COHU) and Transcat (TRNS) - May 11 at 5:01 PM
Reviewing Transcat (TRNS) & EXFO (EXFO)Reviewing Transcat (TRNS) & EXFO (EXFO) - May 11 at 1:14 AM
Transcat Announces Fourth Quarter and Full Fiscal Year 2018 Conference Call and WebcastTranscat Announces Fourth Quarter and Full Fiscal Year 2018 Conference Call and Webcast - May 10 at 10:42 AM
 Analysts Set $20.00 Price Target for Transcat, Inc. (TRNS) Analysts Set $20.00 Price Target for Transcat, Inc. (TRNS) - May 4 at 5:28 PM
Comparing Transcat (TRNS) and Analogic (ALOG)Comparing Transcat (TRNS) and Analogic (ALOG) - April 27 at 11:37 AM
Woodward (WWD) Earnings and Revenues Trump Estimates in Q2Woodward (WWD) Earnings and Revenues Trump Estimates in Q2 - April 24 at 3:53 PM
Brokerages Anticipate Transcat, Inc. (TRNS) to Announce $0.23 EPSBrokerages Anticipate Transcat, Inc. (TRNS) to Announce $0.23 EPS - April 19 at 1:36 PM
Aehr Test Systems (AEHR) & Transcat (TRNS) Financial SurveyAehr Test Systems (AEHR) & Transcat (TRNS) Financial Survey - April 12 at 5:40 PM
Transcat (TRNS) Rating Increased to Buy at ValuEngineTranscat (TRNS) Rating Increased to Buy at ValuEngine - April 11 at 12:04 PM
Transcat (TRNS) Rating Lowered to Hold at Zacks Investment ResearchTranscat (TRNS) Rating Lowered to Hold at Zacks Investment Research - April 5 at 4:06 PM
Zacks: Transcat, Inc. (TRNS) Given $20.00 Average Price Target by BrokeragesZacks: Transcat, Inc. (TRNS) Given $20.00 Average Price Target by Brokerages - April 4 at 9:18 PM
Contrasting Transcat (TRNS) and Analogic (ALOG)Contrasting Transcat (TRNS) and Analogic (ALOG) - April 4 at 11:23 AM
Transcat (TRNS) & Siliconware Precision Industries (SPIL) Financial ReviewTranscat (TRNS) & Siliconware Precision Industries (SPIL) Financial Review - March 19 at 9:22 PM
Head to Head Review: CTS (CTS) vs. Transcat (TRNS)Head to Head Review: CTS (CTS) vs. Transcat (TRNS) - March 16 at 7:24 PM
Transcat (TRNS) Downgraded by Zacks Investment Research to HoldTranscat (TRNS) Downgraded by Zacks Investment Research to Hold - March 9 at 8:42 PM
Transcat (TRNS) Stock Rating Upgraded by Zacks Investment ResearchTranscat (TRNS) Stock Rating Upgraded by Zacks Investment Research - March 8 at 7:03 PM
Transcat (TRNS) and CTS (CTS) Head to Head AnalysisTranscat (TRNS) and CTS (CTS) Head to Head Analysis - March 6 at 10:56 AM
Critical Analysis: Transcat (TRNS) vs. Its CompetitorsCritical Analysis: Transcat (TRNS) vs. Its Competitors - March 5 at 9:32 AM
Transcat (TRNS) & Its Competitors Head-To-Head AnalysisTranscat (TRNS) & Its Competitors Head-To-Head Analysis - March 4 at 11:06 PM
Reviewing Transcat (TRNS) & Its CompetitorsReviewing Transcat (TRNS) & Its Competitors - March 4 at 11:05 AM
Reviewing Transcat (TRNS) and Its RivalsReviewing Transcat (TRNS) and Its Rivals - March 4 at 1:10 AM
Analyzing Transcat (TRNS) & Its PeersAnalyzing Transcat (TRNS) & Its Peers - March 3 at 3:02 PM
 Transcat, Inc. (TRNS) Given $20.00 Average Target Price by Analysts Transcat, Inc. (TRNS) Given $20.00 Average Target Price by Analysts - March 3 at 1:12 AM
Reviewing Transcat (TRNS) & Its PeersReviewing Transcat (TRNS) & Its Peers - March 2 at 11:22 PM
Critical Contrast: Transcat (TRNS) versus Its CompetitorsCritical Contrast: Transcat (TRNS) versus Its Competitors - March 2 at 9:24 PM
Transcat (TRNS) & The Competition Head-To-Head AnalysisTranscat (TRNS) & The Competition Head-To-Head Analysis - March 1 at 11:12 PM
Head-To-Head Comparison: Transcat (TRNS) vs. Its PeersHead-To-Head Comparison: Transcat (TRNS) vs. Its Peers - March 1 at 11:12 PM
Transcat (TRNS) and The Competition Critical ContrastTranscat (TRNS) and The Competition Critical Contrast - March 1 at 9:14 PM
Comparing Transcat (TRNS) and Its RivalsComparing Transcat (TRNS) and Its Rivals - March 1 at 5:40 PM
Reviewing Transcat (TRNS) & The CompetitionReviewing Transcat (TRNS) & The Competition - February 28 at 1:40 PM
Transcat, Inc. to Present at 30th Annual ROTH Conference and Sidoti & Company Spring 2018 ConferenceTranscat, Inc. to Present at 30th Annual ROTH Conference and Sidoti & Company Spring 2018 Conference - February 28 at 10:24 AM
Contrasting Transcat (TRNS) & Its CompetitorsContrasting Transcat (TRNS) & Its Competitors - February 27 at 3:06 AM
Contrasting Transcat (TRNS) & KEMET (KEM)Contrasting Transcat (TRNS) & KEMET (KEM) - February 26 at 11:30 PM
Financial Review: Transcat (TRNS) & Its RivalsFinancial Review: Transcat (TRNS) & Its Rivals - February 26 at 5:06 PM
Transcat (TRNS) vs. Its Rivals Head-To-Head SurveyTranscat (TRNS) vs. Its Rivals Head-To-Head Survey - February 25 at 5:20 AM
Analyzing Transcat (TRNS) and Its RivalsAnalyzing Transcat (TRNS) and Its Rivals - February 24 at 5:12 PM
Contrasting Transcat (TRNS) & Its RivalsContrasting Transcat (TRNS) & Its Rivals - February 24 at 5:12 PM
Financial Contrast: Transcat (TRNS) and Its RivalsFinancial Contrast: Transcat (TRNS) and Its Rivals - February 24 at 3:02 PM
Analyzing Transcat (TRNS) and The CompetitionAnalyzing Transcat (TRNS) and The Competition - February 24 at 3:02 PM
Head to Head Analysis: Transcat (TRNS) versus Its RivalsHead to Head Analysis: Transcat (TRNS) versus Its Rivals - February 24 at 9:26 AM
Transcat (TRNS) and Its Competitors Critical AnalysisTranscat (TRNS) and Its Competitors Critical Analysis - February 23 at 5:32 PM
 Transcat, Inc. (TRNS) Given Consensus Rating of "Strong Buy" by Analysts Transcat, Inc. (TRNS) Given Consensus Rating of "Strong Buy" by Analysts - February 23 at 4:40 PM
Comparing Transcat (TRNS) & Its RivalsComparing Transcat (TRNS) & Its Rivals - February 22 at 11:13 PM
Transcat (TRNS) and Its Competitors Financial ContrastTranscat (TRNS) and Its Competitors Financial Contrast - February 22 at 9:16 PM
Financial Contrast: Transcat (TRNS) vs. The CompetitionFinancial Contrast: Transcat (TRNS) vs. The Competition - February 21 at 7:13 PM
Comparing Transcat (TRNS) and Its PeersComparing Transcat (TRNS) and Its Peers - February 20 at 9:08 PM
Head to Head Analysis: Transcat (TRNS) & Its PeersHead to Head Analysis: Transcat (TRNS) & Its Peers - February 20 at 5:32 PM
Critical Analysis: Transcat (TRNS) & Its CompetitorsCritical Analysis: Transcat (TRNS) & Its Competitors - February 19 at 9:10 PM

SEC Filings

Transcat (NASDAQ:TRNS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Transcat (NASDAQ:TRNS) Income Statement, Balance Sheet and Cash Flow Statement


Transcat (NASDAQ TRNS) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.